Novo Nordisk Investor Presentation - First Nine Months of 2016

Investor presentation First nine months of 2016 Solid position in the diabetes care market across all regions with leading insulin market share Slide 39 Regions Diabetes care value market composition Diabetes care value market share Insulin market volume composition Insulin volume market share 29% 38% USA 60% 71% 29% 51% 63% 37% 11% 11% 48% 41% Europe 43% 72% 28% 40% 54% 46% 9% 19% International Operations¹ 36% 24% 61% 79% 21% 30% 45% 55% 3% 46% 21% Region China¹ 52% 47% 68% 32% 16% 45% 55% 63% 1% Pacific 24% 36% 72% 4% 79% 21% 44% 53% 47% 20% 1 IMS only covers part of the channels in International Operations and Region China Source: IMS August 2015 & 2016 Monthly MAT volume and value (DKK) figures changing diabetes® Insulin GLP-1 OAD Novo Nordisk Others Fast-acting Novo Nordisk Premix Others Long-acting novo nordisk

View entire presentation